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The authors recently became aware of an error in the top panel of Figure 2D showing the expression of ERBB3. An incorrect panel,
meant to show ERBB3 expression, was inadvertently included when the figure was originally assembled. The incorrect panel has
been replaced below with the correct western blot showing the expression of ERBB3. The correction does not affect the findings
reported in the paper. The authors apologize for any confusion the error may have caused.Cancer Cell 25, 543–548, April 14, 2014 ª2014 Elsevier Inc. 543
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Figure 2. ERBB3 Mutants Support Transformation and In Vivo Tumor Growth of IMCE Colonic Epithelial Cells
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